Invicro is a next-generation quantitative imaging biomarker company focused on accelerating the drug discovery and development process for pharmaceutical and biotech companies. Our solutions allow researchers to visualize and quantitate drug targets, evaluate and measure drug delivery, monitor and quantify drug effects, and assess and predict drug response. We design, execute, analyze, and report on drug development pipelines using advanced imaging endpoints across preclinical drug discovery, and early to late phase clinical trials.

Contact us